Angeline Galiano
Family Medicine · Tampa, FLNPI 1023339629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations.
Across 241 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Antares Pharma, Inc.$525
- Lilly USA, LLC$400
- Abbott$378
- AbbVie$318
- Noven Therapeutics, LLC$249
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,632100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 62 | $1,101 |
| Antares Pharma, Inc. | 24 | $525 |
| Lilly USA, LLC | 22 | $400 |
| Abbott | 18 | $378 |
| AbbVie | 16 | $318 |
| Noven Therapeutics, LLC | 11 | $249 |
| IBSA Pharma Inc. | 9 | $194 |
| Pfizer | 9 | $171 |
| Amgen | 8 | $147 |
| Exact Sciences | 7 | $139 |
| Acella Pharmaceuticals, LLC | 7 | $121 |
| Astellas Pharma US Inc | 5 | $117 |
| Halozyme Inc | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| Supernus Pharmaceuticals, Inc. | 4 | $70 |
| Azurity Pharmaceuticals, Inc. | 3 | $60 |
| Idorsia Pharmaceuticals US Inc | 4 | $58 |
| Sanofi-aventis U.S. LLC | 2 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $48 |
| Eisai Inc. | 2 | $46 |
| Radius Health, Inc. | 2 | $41 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Corium, LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Tolmar, Inc. | 1 | $15 |
How this compares
$4,632 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 22 | $129 |
| Losartan Potassium | 19 | $124 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tampa
- Emily HornTampa$184K
- Mark SeldesTampa$36K
- Robert MirskyTampa$31K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.